JPWO2021192472A1 - - Google Patents
Info
- Publication number
- JPWO2021192472A1 JPWO2021192472A1 JP2022509276A JP2022509276A JPWO2021192472A1 JP WO2021192472 A1 JPWO2021192472 A1 JP WO2021192472A1 JP 2022509276 A JP2022509276 A JP 2022509276A JP 2022509276 A JP2022509276 A JP 2022509276A JP WO2021192472 A1 JPWO2021192472 A1 JP WO2021192472A1
- Authority
- JP
- Japan
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/20—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2020053443 | 2020-03-24 | ||
PCT/JP2020/048666 WO2021192472A1 (ja) | 2020-03-24 | 2020-12-25 | ペメトレキセド製剤 |
Publications (1)
Publication Number | Publication Date |
---|---|
JPWO2021192472A1 true JPWO2021192472A1 (ja) | 2021-09-30 |
Family
ID=77891250
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2022509276A Pending JPWO2021192472A1 (ja) | 2020-03-24 | 2020-12-25 |
Country Status (2)
Country | Link |
---|---|
JP (1) | JPWO2021192472A1 (ja) |
WO (1) | WO2021192472A1 (ja) |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SI2854768T1 (sl) * | 2012-05-30 | 2017-08-31 | Fresenius Kabi Oncology Limited | Farmacevtski sestavki pemetrekseda |
WO2014198337A1 (en) * | 2013-06-14 | 2014-12-18 | Synthon B.V. | Stable and water soluble pharmaceutical compositions comprising pemetrexed |
JP6120766B2 (ja) * | 2013-12-27 | 2017-04-26 | 富士フイルム株式会社 | 注射液製剤及びその製造方法 |
GB201511246D0 (en) * | 2015-06-25 | 2015-08-12 | Actavis Group Ptc Ehf | Pharmaceutical formulation |
WO2018056336A1 (ja) * | 2016-09-21 | 2018-03-29 | ナガセ医薬品株式会社 | ペメトレキセド製剤 |
JP2019019075A (ja) * | 2017-07-14 | 2019-02-07 | 東和薬品株式会社 | ペメトレキセド含有液状医薬組成物 |
-
2020
- 2020-12-25 WO PCT/JP2020/048666 patent/WO2021192472A1/ja active Application Filing
- 2020-12-25 JP JP2022509276A patent/JPWO2021192472A1/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
WO2021192472A1 (ja) | 2021-09-30 |
Similar Documents
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20221007 |
|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20230725 |